Search clinical trials for: Acarbose (Glucobay, BAYG5421)

Total 124 results

Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease (ABDOMEN)

Diabetes Mellitus

Poland
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Diabetes Mellitus

Spain
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Sulfonylurea

Type 2 Diabetes Mellitus

India
Bayer

Completed

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting (CATERING)

Diabetes Mellitus

Poland
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Metformin

Type 2 Diabetes Mellitus

India
Bayer

Completed

Bioequivalence Study for Acarbose / Metformin FDC

Diabetes Mellitus, Type II

Korea, Republic of
Bayer

Completed

Glucose Reduction by Early Acarbose Treatment in Basal Insulin (GREAN)

Diabetes Mellitus, Type 2

Korea, Republic of
Aichi Gakuin University

Unknown

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Coronary Artery Disease | Diabetes Mellitus | Impaired Glucose Tolerance

Japan
Bayer

Withdrawn

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice (GLORY)

Diabetes Mellitus, Type 2
Bayer

Completed

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients (GLOBE)

Type 2 Diabetes

India
Bayer

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Diabetes Mellitus, Type 2

China
Novartis Pharmaceuticals

Completed

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Diabetes Mellitus, Type 2

China
Kenneth Madden

Completed

Acarbose and Older Adults With Postprandial Hypotension (PPH)

Syncope | Other Specified Hypotension

Canada
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Glucose Intolerance | Cardiovascular Risk Factor | Postprandial Hyperglycemia

Mexico
Peking University

Unknown

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients (VISA-T2DM)

Obesity | Diabetes Mellitus, Type 2

China
University of Oxford
Bayer

Completed

Acarbose Cardiovascular Evaluation Trial (ACE)

Coronary Heart Disease | Acute Coronary Syndrome | Impaired Glucose Tolerance | Type 2 Diabetes Mellitus (T2DM)

China, Hong Kong
Shanghai Jiao Tong University School of Medicine

Unknown

Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

Type 2 Diabetes

China
Taipei Veterans General Hospital, Taiwan

Unknown

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Diabetes

Taiwan
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers

Healthy
Bayer

Withdrawn

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy (STARCH AM)

Diabetes Mellitus
Takeda

Completed

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Novo Nordisk A/S

Completed

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines (AlfaEx)

Glucose Metabolism Disorders

Denmark
Shanghai 6th People's Hospital

Unknown

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin (CGMS)

Type 2 Diabetes

China
Zealand University Hospital

Completed

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Obesity | Hypoglycemia | Surgery
Medical University of Graz

Completed

Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics

Type 1 Diabetes

Austria
EMS

Completed

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Brazil
AstraZeneca

Completed

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy (SMART)

Type 2 Diabetes Mellitus

China
Zilin Sun

Completed

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

Type 2 Diabetes

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Unknown

Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Medical University of Graz

Completed

Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Type 2 Diabetes

Austria
Medical University of Graz

Completed

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management

Type 2 Diabetes

Austria
Guiyang Medical University

Not yet recruiting

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Head and Neck Squamous Carcinoma

China
Radboud University Medical Center

Completed

Vildagliptin and Endothelium-dependent Vasodilatation

Type 2 Diabetes | Endothelial Dysfunction

Netherlands
The Cleveland Clinic

Completed

Bexarotene Amyloid Treatment for Alzheimer's Disease (BEAT-AD)

Alzheimer's Disease

United States
The University of Texas Health Science Center at...

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Aging

United States
GWT-TUD GmbH
Technische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...

Completed

AI(I)DA Acarbose and the Subclinical Inflammation

Type 2 Diabetes Mellitus | Subclinical Inflammation

Germany
GWT-TUD GmbH

Completed

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Metabolic Syndrome

Germany
Technische Universität Dresden

Completed

Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes
AgelessRx

Completed

The Efficacy and Tolerability of Acarbose in Healthy Individuals

Tolerance | Side Effect | Glucose Response

United States
Karolinska Institutet
Bayer; The Swedish Research Council

Completed

Exercise and Acarbose in Type 2 Diabetes

Diabetes Mellitus Type 2

Sweden
Indiana University

Completed

Mobile Communication Technology for Adolescents With Diabetes

Type 1 Diabetes

United States
University of Alabama at Birmingham

Not yet recruiting

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
Lotus Pharmaceutical

Unknown

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.

Taiwan
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Food Intake and the Adolescent Brain (ADOB)

Adolescent | Feeding Behavior | Brain

United States

3

Subscribe